VOLORIDGE INVESTMENT MANAGEMENT, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,877,014
+5.9%
97,979
+0.0%
0.06%
+11.3%
Q2 2023$11,220,326
-72.3%
97,977
-66.7%
0.05%
-73.8%
Q1 2023$40,550,964
+94.5%
294,210
+82.9%
0.20%
+74.1%
Q4 2022$20,845,405
+186.6%
160,869
+144.5%
0.12%
+197.4%
Q3 2022$7,274,000
+411.2%
65,803
+246.5%
0.04%
+457.1%
Q2 2022$1,423,000
-86.5%
18,990
-85.9%
0.01%
-88.3%
Q1 2022$10,558,000
-19.3%
135,151
-7.0%
0.06%
-16.7%
Q4 2021$13,086,000
-21.9%
145,322
-19.7%
0.07%
-33.3%
Q3 2021$16,745,000
-35.6%
181,067
-45.9%
0.11%
-40.0%
Q2 2021$26,002,000
-34.4%
334,471
-37.1%
0.18%
-37.9%
Q1 2021$39,647,000
+745.7%
531,955
+1719.3%
0.29%
+437.0%
Q2 2020$4,688,000
-46.0%
29,240
-74.6%
0.05%
-64.2%
Q3 2019$8,682,000
+95.5%
115,270
+183.3%
0.15%
-24.9%
Q4 2018$4,440,000
-75.5%
40,684
-70.3%
0.20%
-58.6%
Q2 2018$18,124,000
+47.4%
137,118
-17.4%
0.49%
+67.6%
Q1 2018$12,296,000
+42.2%
165,966
+6.8%
0.29%
+54.3%
Q4 2017$8,647,000
+97.6%
155,404
-2.6%
0.19%
+100.0%
Q4 2016$4,377,000
+1828.2%
159,580
+4213.0%
0.09%
+1780.0%
Q3 2016$227,000
-81.4%
3,700
-90.3%
0.01%
-91.2%
Q3 2015$1,220,00037,9970.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders